Co-Founder and
Managing Director
Head of Research
As we embark upon another financial year, a second wave of global COVID-19 infections and lockdown restrictions remain a systematic risk for investment markets. In this situation, many companies, specifically in tourism, hospitality, and leisure, are vulnerable to closure as cashflows dry up. Companies like Virgin Australia and Speedcast International have already gone into administration. Fortunately, Stock Doctor members benefit from Lincoln’s investment process, helping avoid these stocks via the lens of our proprietary Financial Health model. This ensures they stay on the right side of insolvency risk, especially as the reporting season approaches.
Using our proprietary methodology by selecting financially healthy quality stocks, our Star Growth and Star Income portfolios have significantly outperformed the market, returning 17.8% p.a. since inception (1/9/1995-30/7/2020) and 13.8% p.a. since inception (7/8/2012-30/7/2020) respectively^. This methodology has also helped our Australian Growth Fund rank first for 3-year performance from 514 Australian Equity Funds according to Money Management*.
We invite you to watch our webinar recording, where Tim Lincoln, Co-Founder and Managing Director, and Kien Trinh, Head of Research, share insights on how you can use Stock Doctor to successfully manage and grow your investments.
Agenda
Co-Founder and
Managing Director
Head of Research
To discuss the future of your investments in detail, book in a free consultation with a Lincoln representative.
To discuss the future of your investments in detail, book in a free consultation with a Lincoln financial expert.